NYSE:MCK - McKesson Stock Price, Forecast & News

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

McKesson declared a quarterly dividend on Wednesday, October 23rd. Investors of record on Monday, December 2nd will be given a dividend of $0.41 per share on Thursday, January 2nd. This represents a $1.64 annualized dividend and a dividend yield of 1.07%. The ex-dividend date is Friday, November 29th. View McKesson's Dividend History.

McKesson Co. (NYSE:MCK) announced its earnings results on Wednesday, October, 30th. The company reported $3.60 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $3.60. The business earned $57.62 billion during the quarter, compared to analyst estimates of $55.06 billion. McKesson had a negative net margin of 0.29% and a positive return on equity of 32.77%. The firm's revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $3.60 earnings per share. View McKesson's Earnings History.

McKesson is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for McKesson.

McKesson will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

McKesson updated its FY20 earnings guidance on Monday, January, 13th. The company provided earnings per share guidance of $14.60-14.80 for the period, compared to the Thomson Reuters consensus EPS estimate of $14.38.

10 brokers have issued 12-month price targets for McKesson's stock. Their forecasts range from $140.00 to $170.00. On average, they anticipate McKesson's share price to reach $154.78 in the next twelve months. This suggests a possible upside of 1.4% from the stock's current price. View Analyst Price Targets for McKesson.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for McKesson.

Headlines about MCK stock have trended somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. McKesson earned a daily sentiment score of 2.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the near term. View News Stories for McKesson.

McKesson saw a decline in short interest in the month of December. As of December 13th, there was short interest totalling 3,670,000 shares, a decline of 13.2% from the November 28th total of 4,230,000 shares. Based on an average daily trading volume, of 1,610,000 shares, the short-interest ratio is presently 2.3 days. Currently, 2.0% of the shares of the stock are sold short. View McKesson's Current Options Chain.

Some companies that are related to McKesson include AmerisourceBergen (ABC), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include Walt Disney (Dis), Gilead Sciences (GILD), Allergan (AGN), CVS Health (CVS), UnitedHealth Group (UNH), Johnson & Johnson (JNJ), AbbVie (ABBV), Boeing (BA), salesforce.com (crm) and NVIDIA (NVDA).

McKesson's stock is owned by many different of institutional and retail investors. Top institutional shareholders include PGGM Investments (0.17%), Wedge Capital Management L L P NC (0.16%), New York State Teachers Retirement System (0.15%), Strs Ohio (0.12%), Zurcher Kantonalbank Zurich Cantonalbank (0.07%) and Nisa Investment Advisors LLC (0.05%). Company insiders that own McKesson stock include Brian S Tyler, Brian Scott Tyler, Britt J Vitalone, Erin M Lampert, Lori A Schechter, M Christine Jacobs, N Anthony Coles and Sundeep G Reddy. View Institutional Ownership Trends for McKesson.

MCK stock was sold by a variety of institutional investors in the last quarter, including PGGM Investments, Assenagon Asset Management S.A., Artemis Investment Management LLP, Kempner Capital Management Inc., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Nisa Investment Advisors LLC, Calamos Advisors LLC and State of Alaska Department of Revenue. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Brian Scott Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs and Sundeep G Reddy. View Insider Buying and Selling for McKesson.

MCK stock was purchased by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Contravisory Investment Management Inc., Patton Fund Management Inc., DNB Asset Management AS, Zurcher Kantonalbank Zurich Cantonalbank, Campbell & CO Investment Adviser LLC, Donald L. Hagan LLC and Janney Montgomery Scott LLC. View Insider Buying and Selling for McKesson.

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MCK stock can currently be purchased for approximately $152.62.

McKesson has a market capitalization of $27.50 billion and generates $214.32 billion in revenue each year. The company earns $34 million in net income (profit) each year or $13.57 on an earnings per share basis. McKesson employs 80,000 workers across the globe.View Additional Information About McKesson.

The official website for McKesson is http://www.mckesson.com/.

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]